You ever read an article and feel an uncomfortable chill? That’s what we felt when we read this recent column by New York Times columnist Farhad Manjoo. In a column titled, “Abortion Pills Should Be Everywhere“, Manjoo exposes how easy it is to buy RU-486 abortion drugs online.
Manjoo starts with this story, “One afternoon about a year ago, just as the Senate began considering Brett Kavanaugh’s nomination to the Supreme Court, I logged on to Day Night Healthcare, an online pharmacy based in India, and ordered a pack of abortion pills. A few hours later, I got a call from a Day Night customer-service agent with a warning. If my credit-card company called to ask about the purchase, “tell them you approve the charge, but don’t say what it’s for,” the man advised. “If they ask, say it’s gym equipment, or something like that.'”
First, is there a reason that Manjoo, who is definitively not pregnant, was buying abortion drugs? Second, should the New York Times be promoting a columnist who admits he was ready to commit fraud just to get his hands on abortion drugs?
Of course we know, that abusive men want abortion drugs so that they can sometimes trick women into getting abortions. We’re not accusing that of being Manjoo’s motivation of course, but to show how easy it is for men to obtain abortion drugs without much of a tracking system or oversight. We know that abusive men have used RU-486 to try to force women into having abortions.
And the tragic story of Ally Kostial, an Ole Miss undergraduate student who was murdered allegedly by the father of her child because she refused to have an abortion, shows how abusive men will use abortion as an act of violence.
Manjoo continues, by praising the black market in drugs, writing, “Yet thanks to the digital handiwork of an emerging faction within the global reproductive-rights movement, restrictions on abortion pills are becoming increasingly difficult to enforce. Despite the F.D.A.’s restrictions, activists have created a robust online market that makes getting pills surprisingly easy. There are “report cards” on where to find tested drugs, detailed guides on how to use them safely, a help line for consulting with legal experts, and dozens of discussion boards and support groups helping women navigate the fraught decision of whether and how to terminate a pregnancy.”
Manjoo downplays the dangers of RU-486 abortion drugs. For example, a recent study at Franciscan University found, “pregnancy termination at mid-term (first-trimester human equivalent) induces significant negative biological and behavioral changes in the rat. Additionally, such a procedure appears to be associated with a potential absence of beneficial effects of carrying a pregnancy to full-term. Moreover, our findings also appear to indicate a significant difference between induced pregnancy termination (medical abortion) and natural miscarriage. Our study, therefore, indicates the importance and necessity for further objective research into the abortion procedure, including at the physiological and neurophysiological levels. Such work may further our understanding and potentially shed some clarity into the potential biobehavioral impact of such a procedure at the level of the human person.”
You can read more about the dangers of RU-486 abortion drugs at NoCampusAbortions.com.